Project leaders: Benjamin Gmeiner, Claudia Quiering, Bjoern Eskofier
Project members: Tatiana Merzhevich
Start date: 15.12.2023
End date: 21.12.2026
Funding source: Novartis Pharma GmbH
Abstract
Clinical trials are essential for developing safe and effective medical treatments, yet they face high failure rates, extensive timelines, and substantial costs. Current Artificial Intelligence (Al) and data analytics tools have the potential to transform clinical research, improve its efficiency, optimize outcomes, and reduce expenses to advance medical research. This project aims to modernize clinical research and accelerate the development of new treatments by leveraging Al and Machine Learning (ML) algorithms and to align clinical practice with evolving healthcare landscapes to ensure efficient and cost-effective solutions for overall health and well-being.
